Home -> Law Blog Directory -> Law Technology Blogs -> TechnoLawyer Blog

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Law Technology

: TechnoLawyer Blog

Review of Top Six New Features for Law Firms in Word 2010

By Sara Skiff

Coming today to TechnoFeature: Every law firm needs word processing software to produce their work. But does every law firm need to upgrade to Microsoft Word 2010, the new version of the world's most popular word processor? That's the question Word expert and trainer Jan Berinstein answers in this TechnoFeature article. Specifically, she assesses the six most important new features in Word 2010 from a law firm's perspective. What does Jan think? Read her analysis to find out. How to Receive TechnoFeature Our flagship newsletter never disappoints thanks to its in-depth reporting by leading legal technology and practice management experts, many of whom have become "household names" in the legal profession. It's in TechnoFeature that you'll find our oft-quoted formal product reviews and accompanying TechnoScore ratings...continue to full post

Full post as published by TechnoLawyer Blog on August 10, 2010 (boomark / email).

Lawsuits and Settlements

Whole Foods
And Other Firms Sued by California Attorney General,

FDA Issues Update on Safety Review Orlistat
Orlistat FDA Issues Update on Safety Review

Brown Greer et al.
alleging that the six law firms handling the Vioxx settlement failed to provide money for reimbursements to lien rights of Employee Retirement Income Security Act (ERISA) health plans.

Aurora Loan Faces Class Action over Mortgage Review Services
Aurora Loan Faces Class Action over Mortgage Review Services

FDA Review of Prostate Cancer Treatment Prompts Warning of Risk for Diabetes
Prostate Cancer Treatment FDA Review Prompts Warning of Risk for Diabetes

Xigris
Study Prompts FDA Safety Review

Related Searches